Mixed Result for Bone Drug in Cancer Study

Thursday, December 9, 2010 - 21:50 in Health & Medicine

A new study is tempering hopes that zoledronic acid, a bone-loss drug, might also help stave off relapses of breast cancer, especially for younger women.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net